Controlled multicenter trial of tiopronin and D‐penicillamine for rheumatoid arthritis

Authors:

Abstract
Fifty‐seven patients took part in a controlled double‐blind trial between tiopronin and D‐penicillamine as basic treatment for rheumatoid arthritis. Thirty‐nine (19 receiving tiopronin, 20 receiving D‐penicillamine) completed the trial after 1 year. Both drugs resulted in a decrease of the erythrocyte sedimentation rate, Ritchie index, and Lee index and in a sparing effect on symptomatic antiinflammatory therapy. Improvement in these variables was statistically highly significant at any interval with tiopronin, but was sometimes less or not at all significant with D‐penicillamine. Nevertheless, the difference in effects between the 2 drugs never reached statistical significance. Six patients receiving tiopronin and 6 receiving D‐penicillamine were taken out of the experiment because of side effects.

This publication has 18 references indexed in Scilit: